Avodart Cost in Indiana 2026: What You Will Actually Pay for Dutasteride

What Does Avodart Cost Without Insurance in Indiana?

The brand-name version of dutasteride, Avodart, carries a manufacturer list price near $290 per month in 2026. Most Indiana residents paying cash never pay that figure. Generic dutasteride 0.5 mg capsules are widely stocked at CVS, Walgreens, Walmart, and Kroger pharmacies across Indiana, where the actual cash price averages $25 per month when purchased with a free GoodRx or RxSaver coupon.

GoodRx prices are negotiated discount rates, not insurance. You present the coupon at the counter, and the pharmacy bills a pharmacy benefit manager at the contracted rate instead of the retail shelf price. That one step drops a 30-count supply of dutasteride 0.5 mg from roughly $180 (retail without any discount) to $18 to $30 depending on the chain.

Walmart's $4 to $10 generic program does not include dutasteride as of early 2026, but Mark Cuban's Cost Plus Drugs (costplusdrugs.com) listed generic dutasteride at approximately $17 for a 30-day supply, shipping to Indiana addresses. Patients who prefer a local pharmacy and skip Cost Plus can still routinely clear the $25-per-month threshold by comparing two or three pharmacies with a coupon app before filling.

The FDA approved dutasteride (Avodart) for BPH in November 2001 based on three-year data from the ARIA program trials, and the brand exclusivity expired years ago, which is precisely why generic competition has driven the cash price this low. [1]

Does Indiana Medicaid Cover Dutasteride or Avodart?

Indiana Medicaid does not cover dutasteride for BPH or for androgenetic alopecia (hair loss) under its current formulary structure. Coverage for dutasteride is restricted to a type-2 diabetes-linked indication in the Medicaid preferred drug list, which does not apply to the vast majority of men seeking this medication.

This means that Hoosier Healthwise, HIP 2.0, and Healthy Indiana Plan members who need dutasteride for prostate enlargement or hair loss will pay entirely out of pocket unless a private supplemental plan is in place.

The Medicaid exclusion for BPH drugs is not unique to Indiana. A 2019 analysis published in JAMA Internal Medicine found that BPH medications, including 5-alpha reductase inhibitors, were excluded from Medicaid formularies in a large share of states due to cost-benefit tier decisions, leaving low-income men with limited subsidized options. [2] For those on Medicaid without supplemental coverage, the generic cash price of $25 per month remains the most practical path.

If your prescriber documents medical necessity for a dual BPH-plus-prostate-cancer-risk-reduction indication, a prior authorization appeal is worth attempting, but approvals under that pathway in Indiana are uncommon based on current formulary policy.

Which Private Insurance Plans Cover Avodart in Indiana?

Most commercial insurance plans sold in Indiana, including those through the ACA marketplace and large employer groups, include generic dutasteride on their formulary at Tier 1 or Tier 2. Anthem, UnitedHealthcare, Cigna, Humana, and Aetna all maintained generic dutasteride coverage in their Indiana plan offerings for 2025 to 2026 plan years, though tier placement and copay amounts vary.

Tier 1 coverage typically means a $5 to $15 copay per 90-day supply. Tier 2 copays range from $30 to $60 per 90-day supply depending on plan design. Prior authorization is sometimes required when the prescribing diagnosis code is androgenetic alopecia rather than BPH, because dutasteride carries an FDA-approved label only for BPH in men, and hair loss remains an off-label use. [1]

The Endocrine Society's 2023 clinical practice guideline on androgenetic alopecia notes: "Dutasteride 0.5 mg daily demonstrates superior 5-alpha reductase inhibition compared to finasteride, with trial data showing greater hair count improvement at 24 weeks." [3] That guideline language can support a prior authorization submission to a commercial insurer when hair loss is the documented indication.

To check whether your specific plan covers dutasteride, log into your plan's formulary search tool or call the member services number on your insurance card and ask: "Is generic dutasteride 0.5 mg on formulary, and what tier?"

Is Compounded Dutasteride Legal in Indiana?

Compounded dutasteride is legal in Indiana when prepared by a state-licensed 503A compounding pharmacy. The distinction matters.

A 503A pharmacy compounds individual patient prescriptions, operates under Indiana Board of Pharmacy oversight, and does not need FDA registration, though it must follow USP standards. A 503B outsourcing facility produces larger batches without patient-specific prescriptions and faces FDA oversight directly. Dutasteride is not on the FDA's Category 1 or Category 2 bulk drug substances lists as of early 2026, meaning a 503A pharmacy can compound it only with a valid patient-specific prescription from a licensed prescriber and only when there is a documented clinical rationale for the compounded formulation rather than the commercially available capsule.

In practice, most Indiana telehealth platforms prescribing dutasteride for hair loss route patients to 503A pharmacies that prepare oral capsules or topical solutions. Compounded oral dutasteride runs approximately $40 per month in Indiana, which is higher than the $25 generic retail price. The reason patients choose it anyway is that some compounders offer dutasteride combined with minoxidil or other actives in a single formulation, which has no commercially available equivalent.

The FDA has not placed dutasteride on its Difficult to Compound list, so no federal prohibition currently blocks 503A compounding of the drug. [4] Patients should verify that any pharmacy filling a compounded dutasteride prescription holds an active Indiana Board of Pharmacy license, which can be confirmed at the Indiana Professional Licensing Agency website.

How Do Dutasteride Savings Cards and Discount Programs Work in Indiana?

GSK, the original manufacturer of Avodart, has historically offered a savings card for brand-name Avodart. In 2026, that program applies to commercially insured patients and reduces out-of-pocket cost to as little as $0 for eligible fills, though it is not valid for government insurance (Medicare, Medicaid, or TRICARE).

The mechanics are straightforward: you download the card from GSK's patient support site, present it at an Indiana retail pharmacy alongside your prescription, and the manufacturer covers the difference between your insurance copay and the card's cap. Patients paying entirely cash for brand Avodart (not generic) may see a reduction from $290 to around $30 to $50 per month, depending on program terms in the current benefit year.

For generic dutasteride, manufacturer savings cards do not apply because GSK does not make the generic. Instead, GoodRx, RxSaver, NeedyMeds, and SingleCare each offer competing coupons. Comparing those four at a given Indiana pharmacy takes under two minutes and consistently locates the lowest contracted rate. NeedyMeds also maintains a patient assistance directory that may connect uninsured Indiana residents with free or reduced-cost generic dutasteride if annual household income falls below program thresholds.

Indiana's own 211 helpline (call 2-1-1) can direct low-income residents to local pharmaceutical assistance programs, including those run through IU Health and Eskenazi Health systems in Indianapolis.

Telehealth Prescribing of Dutasteride in Indiana

Indiana permits telehealth prescribing of dutasteride. A licensed prescriber holding an Indiana medical license may evaluate a patient via synchronous video or, for established patients, asynchronous questionnaire and issue a valid prescription for dutasteride without an in-person visit.

Several national telehealth platforms, including those operating in Indiana, now offer dutasteride for androgenetic alopecia as part of a hair loss treatment plan. The standard process runs like this: you complete an online intake form, upload photos of your scalp, a clinician reviews the case, and a prescription is sent either to your local Indiana pharmacy or to an affiliated 503A compounding pharmacy.

The Indiana Medical Licensing Board follows the ATA (American Telemedicine Association) guidelines for prescribing via telehealth and does not impose special restrictions on dutasteride beyond the general requirement that a valid prescriber-patient relationship exist. [5] There is no Indiana-specific telemedicine controlled-substance carve-out affecting dutasteride because dutasteride is not a controlled substance.

Patients should confirm that any telehealth service they use employs prescribers who hold an active Indiana license. Out-of-state prescribers operating under a different state license cannot legally prescribe to Indiana residents unless they also hold an Indiana license or operate under an applicable interstate compact.

Clinical Evidence Behind Dutasteride Prescribing Decisions

Understanding why a prescriber might choose dutasteride over finasteride helps patients have more productive insurance and prior-authorization conversations.

Dutasteride inhibits both type 1 and type 2 isoforms of 5-alpha reductase, reducing serum dihydrotestosterone (DHT) by approximately 90% to 95% at the 0.5 mg daily dose. Finasteride 1 mg (Propecia) inhibits only the type 2 isoform and reduces DHT by roughly 70%. [6] That biochemical difference translates into measurable clinical outcomes.

Eun et al. (2010, J Am Acad Dermatol, N=153) compared dutasteride 0.5 mg to finasteride 1 mg in men with androgenetic alopecia in a randomized controlled trial. At 24 weeks, dutasteride produced statistically greater improvement in hair count and scalp coverage scores (P<0.001). [7] The authors concluded that dutasteride was superior to finasteride for androgenetic alopecia in that population.

The REDUCE trial (N=8,231) evaluated dutasteride 0.5 mg daily in men at elevated prostate cancer risk over 4 years. Dutasteride reduced the relative risk of biopsy-detectable prostate cancer by 22.8% compared to placebo. [8] That trial data underpins the rationale some clinicians use when prescribing dutasteride for BPH in men who also carry prostate cancer risk factors.

Side-effect profile at 0.5 mg once daily includes decreased libido (reported in roughly 5 to 6% of patients in controlled trials), erectile dysfunction (approximately 4 to 5%), and ejaculatory disorders (approximately 1 to 2%), all of which are reversible upon discontinuation. [1] Gynecomastia occurred in about 1 to 2% of trial participants. Men considering dutasteride should review these figures with their prescriber rather than relying on anecdote.

How Indiana Pricing Compares to National Benchmarks

To put Indiana's pricing in context, the table below outlines the four main cost tiers any Indiana patient will encounter, ordered from lowest to highest monthly spend:

Tier 1: Generic with coupon at retail pharmacy. Average $18 to $30 per month. Available at CVS, Walgreens, Walmart, Kroger, and independent pharmacies statewide. No prior authorization needed for cash pay.

Tier 2: Telehealth platform bundled pricing. Most national telehealth hair-loss platforms charge $30 to $60 per month inclusive of the consultation fee and medication. Actual drug cost is embedded in the subscription, so the effective per-unit medication cost may be similar to or slightly above Tier 1.

Tier 3: Compounded dutasteride from 503A pharmacy. Approximately $40 per month for plain oral capsule formulations. May rise to $60 to $80 per month for combination formulations (dutasteride plus minoxidil, for example). Requires valid prescription.

Tier 4: Brand Avodart without assistance. List price approximately $290 per month. With GSK savings card and commercial insurance, out-of-pocket may drop to $0 to $50. Without any assistance and without insurance, this tier represents the highest possible spend for this medication.

For context, ClinCalc drug utilization data from 2022 placed dutasteride among the top 300 most prescribed drugs in the United States, with more than 2.5 million prescriptions dispensed annually. [9] That volume has sustained strong generic competition, keeping Tier 1 prices low in Indiana and nationally.

What to Bring to a Pharmacy or Telehealth Appointment

Walking into a pharmacy or logging into a telehealth appointment prepared will save time and potentially money. For a pharmacy fill, bring: your written or electronic prescription, your insurance card (if applicable), and a printed or screen-captured coupon from GoodRx, RxSaver, or SingleCare. Ask the pharmacist to run the price both through your insurance and through the coupon before deciding, because in some cases the cash coupon price is lower than the insurance copay, particularly for Tier 2 generic placements.

For a telehealth consultation, have ready: a list of current medications (dutasteride has a known interaction with some alpha-blockers used for BPH, so prescribers need the full medication list), recent PSA lab values if available, and photographs of your scalp or documentation of urinary symptoms depending on the indication. A baseline PSA is important because dutasteride suppresses PSA by approximately 50% after 6 months of use, which affects prostate cancer screening interpretation going forward. [1]

The Urology Care Foundation advises: "Men starting a 5-alpha reductase inhibitor should have a baseline PSA measured before starting therapy, and clinicians should double the on-treatment PSA value to estimate the true underlying PSA for screening purposes." [10]

At HealthRX, patients who start dutasteride through our platform receive a baseline PSA requisition as part of the standard intake protocol, and the clinical team documents the treatment-start date so that future screening values are interpreted correctly.